West Tower Group, LLC Collegium Pharmaceutical, Inc Transaction History

West Tower Group, LLC

  • $46.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$21.16 - $30.8 $9,522 - $13,860
450 Added 101.81%
892 $27.5 Million
Q3 2023

Nov 14, 2023
SELL
$21.23 - $24.28 $32,672 - $37,366
-1,539 Reduced 77.69%
442 $9.88 Million
Q2 2023

Aug 14, 2023
BUY
$21.06 - $24.0 $41,719 - $47,544
1,981 New
1,981 $42.6 Million

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track West Tower Group, LLC Portfolio

Follow West Tower Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Tower Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Tower Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email